Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer

5535.0000 -31.00 (-0.56%)

NSE Dec 26, 2025 15:31 PM

Volume: 40,414

Alkem Laboratories Ltd.

20 May 2023

5535.00

-0.56%

Alkem Labs (SELL): Margin improvement key for revival

Sell: Alkem Laboratories Ltd.

BOB Capital Markets Ltd.

Q4 EBITDA/PAT of Rs 3.5bn/Rs 710mn well short of consensus by 21%/ 79% primarily due to higher operating costs

Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.